Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Dwyer

Showing results (191-200 of 260) with videos related to

Pageof 26
Sort By:
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 12, 2013
Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT)Hiddo J Lambers Heerspink, Misghina Weldegiorgis, Lesley A Inker, et al.
Journal of Cardiac Failure|August 17, 2021
Multinephron Segment Diuretic Therapy to Overcome Diuretic Resistance in Acute Heart Failure: A Single-Center ExperienceZachary L Cox, Bonnie Ann Sarrell, Mary Katherine Cella, et al.
Nucleic Acids Research|February 15, 1996
Antisense oligonucleotide containing an internal, non-nucleotide-based linker promote site-specific cleavage of RNAM A Reynolds, T A Beck, P B Say, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 17, 2012
Estimating baseline kidney function in hospitalized patients with impaired kidney functionEdward D Siew, T Alp Ikizler, Michael E Matheny, et al.
Glomerular Diseases|August 15, 2024
Effects of Dapagliflozin in Patients with Membranous NephropathyGlenn M Chertow, Hiddo Lambers Heerspink, Patrick B Mark, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Arabidopsis thaliana RHAMNOSE 1 condensate formation drives UDP-rhamnose synthesisSterling Field, Yanniv Dorone, Will P Dwyer, et al.
The New England Journal of Medicine|February 21, 2019
Once-Daily Plazomicin for Complicated Urinary Tract InfectionsFlorian M E Wagenlehner, Daniel J Cloutier, Allison S Komirenko, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 2023
Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trialHiddo J L Heerspink, Peter J Greasley, Christine Ahlström, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 25, 2026
Midazolam Dosing During CRRT: A Combined Ex Vivo and Physiologically-Based Pharmacokinetic ApproachAutumn M McKnite, Abdullah Hamadeh, J Porter Hunt, et al.
The New England Journal of Medicine|September 1, 2025
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant HypertensionJohn M Flack, Michel Azizi, Jenifer M Brown, et al.
Pageof 26

Showing results (191-200 of 260) with videos related to

Sort By:
Pageof 26
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|November 12, 2013
Estimated GFR decline as a surrogate end point for kidney failure: a post hoc analysis from the Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan (RENAAL) study and Irbesartan Diabetic Nephropathy Trial (IDNT)Hiddo J Lambers Heerspink, Misghina Weldegiorgis, Lesley A Inker, et al.
Journal of Cardiac Failure|August 17, 2021
Multinephron Segment Diuretic Therapy to Overcome Diuretic Resistance in Acute Heart Failure: A Single-Center ExperienceZachary L Cox, Bonnie Ann Sarrell, Mary Katherine Cella, et al.
Nucleic Acids Research|February 15, 1996
Antisense oligonucleotide containing an internal, non-nucleotide-based linker promote site-specific cleavage of RNAM A Reynolds, T A Beck, P B Say, et al.
Clinical Journal of the American Society of Nephrology : CJASN|March 17, 2012
Estimating baseline kidney function in hospitalized patients with impaired kidney functionEdward D Siew, T Alp Ikizler, Michael E Matheny, et al.
Glomerular Diseases|August 15, 2024
Effects of Dapagliflozin in Patients with Membranous NephropathyGlenn M Chertow, Hiddo Lambers Heerspink, Patrick B Mark, et al.
Biorxiv : the Preprint Server for Biology|March 11, 2024
Arabidopsis thaliana RHAMNOSE 1 condensate formation drives UDP-rhamnose synthesisSterling Field, Yanniv Dorone, Will P Dwyer, et al.
The New England Journal of Medicine|February 21, 2019
Once-Daily Plazomicin for Complicated Urinary Tract InfectionsFlorian M E Wagenlehner, Daniel J Cloutier, Allison S Komirenko, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|August 26, 2023
Efficacy and safety of zibotentan and dapagliflozin in patients with chronic kidney disease: study design and baseline characteristics of the ZENITH-CKD trialHiddo J L Heerspink, Peter J Greasley, Christine Ahlström, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 25, 2026
Midazolam Dosing During CRRT: A Combined Ex Vivo and Physiologically-Based Pharmacokinetic ApproachAutumn M McKnite, Abdullah Hamadeh, J Porter Hunt, et al.
The New England Journal of Medicine|September 1, 2025
Efficacy and Safety of Baxdrostat in Uncontrolled and Resistant HypertensionJohn M Flack, Michel Azizi, Jenifer M Brown, et al.
Pageof 26